{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:06:48Z","timestamp":1788883608812,"version":"build-2803163510"},"reference-count":123,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103003","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:21:22Z","timestamp":1783437682000},"page":"103003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPRing through time: How cutting-edge technology is revolutionizing life sciences and medicine"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7013-1132","authenticated-orcid":false,"given":"Ishani","family":"Banik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Copp\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103003_bib1","first-page":"631","article-title":"Genes, Mutations, and Human Inherited Disease at the Dawn of the Age of Personalized Genomics","volume":"31","author":"Cooper","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2026.103003_bib2","first-page":"47","article-title":"Precise Genome-Editing in Human Diseases: Mechanisms, Strategies and Applications","volume":"9","author":"Zheng","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.omtn.2026.103003_bib3","article-title":"The New Frontier of Genome Engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib4","first-page":"737","article-title":"Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid","volume":"171","author":"Watson","year":"1953","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib5","first-page":"18","article-title":"Host Specificity of DNA Produced by Escherichia Coli. I. Host Controlled Modification of Bacteriophage Lambda","volume":"5","author":"Arber","year":"1962","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103003_bib6","first-page":"37","article-title":"Host Specificity of DNA Produced by Escherichia Coli. II. Control over Acceptance of DNA from Infecting Phage Lambda","volume":"5","author":"Dussoix","year":"1962","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103003_bib7","first-page":"3","article-title":"Highlights of the DNA Cutters: A Short History of the Restriction Enzymes","volume":"42","author":"Loenen","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103003_bib8","first-page":"401","article-title":"Prospects for Human Gene Therapy","volume":"226","author":"Anderson","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib9","first-page":"2026","article-title":"Genetics of Human Cell Line. IV. DNA-Mediated Heritable Transformation of a Biochemical Trait","volume":"48","author":"Szybalska","year":"1962","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103003_bib10","first-page":"5074s","article-title":"Immunotherapy and Gene Therapy of Cancer","volume":"51","author":"Rosenberg","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2026.103003_bib11","first-page":"570","article-title":"Gene Transfer into Humans--Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction","volume":"323","author":"Rosenberg","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib12","first-page":"1155","article-title":"Independent Control of Immunoglobulin Switch Recombination at Individual Switch Regions Evidenced through Cre-loxP-Mediated Gene Targeting","volume":"73","author":"Gu","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib13","first-page":"6232","article-title":"Targeted Oncogene Activation by Site-Specific Recombination in Transgenic Mice","volume":"89","author":"Lakso","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103003_bib14","first-page":"809","article-title":"Zinc Finger-DNA Recognition: Crystal Structure of a Zif268-DNA Complex at 2.1 A","volume":"252","author":"Pavletich","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib15","first-page":"1609","article-title":"Repetitive Zinc-Binding Domains in the Protein Transcription Factor IIIA from Xenopus Oocytes","volume":"4","author":"Miller","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2026.103003_bib16","first-page":"1509","article-title":"Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors","volume":"326","author":"Boch","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib17","first-page":"1501","article-title":"A Simple Cipher Governs DNA Recognition by TAL Effectors","volume":"326","author":"Moscou","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib18","first-page":"757","article-title":"Targeting DNA Double-Strand Breaks with TAL Effector Nucleases","volume":"186","author":"Christian","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/j.omtn.2026.103003_bib19","first-page":"5429","article-title":"Nucleotide Sequence of the Iap Gene, Responsible for Alkaline Phosphatase Isozyme Conversion in Escherichia Coli, and Identification of the Gene Product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.omtn.2026.103003_bib20","first-page":"613","article-title":"Transcription at Different Salinities of Haloferax Mediterranei Sequences Adjacent to Partially Modified PstI Sites","volume":"9","author":"Mojica","year":"1993","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.omtn.2026.103003_bib21","first-page":"7","article-title":"A Putative RNA-Interference-Based Immune System in Prokaryotes: Computational Analysis of the Predicted Enzymatic Machinery, Functional Analogies with Eukaryotic RNAi, and Hypothetical Mechanisms of Action","volume":"1","author":"Makarova","year":"2006","journal-title":"Biol. Direct"},{"key":"10.1016\/j.omtn.2026.103003_bib22","first-page":"1709","article-title":"CRISPR Provides Acquired Resistance against Viruses in Prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib23","first-page":"1843","article-title":"CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA","volume":"322","author":"Marraffini","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib24","first-page":"143","article-title":"CRISPR: New Horizons in Phage Resistance and Strain Identification","volume":"3","author":"Barrangou","year":"2012","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.omtn.2026.103003_bib25","first-page":"67","article-title":"Evolutionary Classification of CRISPR-Cas Systems: A Burst of Class 2 and Derived Variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omtn.2026.103003_bib26","first-page":"244","article-title":"Biological Significance of a Family of Regularly Spaced Repeats in the Genomes of Archaea, Bacteria and Mitochondria","volume":"36","author":"Mojica","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.omtn.2026.103003_bib27","first-page":"960","article-title":"Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes","volume":"321","author":"Brouns","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib28","first-page":"602","article-title":"CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib29","first-page":"777","article-title":"CRISPR\u2013Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing","volume":"87","author":"Gostimskaya","year":"2022","journal-title":"Biochemistry."},{"key":"10.1016\/j.omtn.2026.103003_bib30","first-page":"816","article-title":"A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib31","first-page":"E2579","article-title":"Cas9-crRNA Ribonucleoprotein Complex Mediates Specific DNA Cleavage for Adaptive Immunity in Bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103003_bib32","first-page":"230","article-title":"Targeted Genome Engineering in Human Cells with the Cas9 RNA-Guided Endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103003_bib33","first-page":"2986","article-title":"SHERLOCK: Nucleic Acid Detection with CRISPR Nucleases","volume":"14","author":"Kellner","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2026.103003_bib34","first-page":"870","article-title":"CRISPR-Cas12-Based Detection of SARS-CoV-2","volume":"38","author":"Broughton","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103003_bib35","first-page":"311","article-title":"A Review on the Mechanism and Applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 Proteins Utilized for Genome Engineering","volume":"65","author":"Hillary","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103003_bib36","first-page":"819","article-title":"Multiplex Genome Engineering Using CRISPR\/Cas Systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib37","first-page":"84","article-title":"Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib38","first-page":"823","article-title":"RNA-Guided Human Genome Engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib39","first-page":"726","article-title":"The tracrRNA and Cas9 Families of Type II CRISPR-Cas Immunity Systems","volume":"10","author":"Chylinski","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2026.103003_bib40","article-title":"RNA-Programmed Genome Editing in Human Cells","volume":"2","author":"Jinek","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.omtn.2026.103003_bib41","first-page":"227","article-title":"Efficient In Vivo Genome Editing Using RNA-Guided Nucleases","volume":"31","author":"Hwang","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103003_bib42","first-page":"720","article-title":"Generation of Gene-Modified Mice via Cas9\/RNA-Mediated Gene Targeting","volume":"23","author":"Shen","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2026.103003_bib43","first-page":"3728","article-title":"Targeted Genomic Rearrangements Using CRISPR\/Cas Technology","volume":"5","author":"Choi","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103003_bib44","first-page":"3964","article-title":"Engineering Human Tumour-Associated Chromosomal Translocations with the RNA-Guided CRISPR\u2013Cas9 System","volume":"5","author":"Torres","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103003_bib45","first-page":"423","article-title":"In Vivo Engineering of Oncogenic Chromosomal Rearrangements with the CRISPR\/Cas9 System","volume":"516","author":"Maddalo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib46","first-page":"1370","article-title":"One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR\/Cas-Mediated Genome Engineering","volume":"154","author":"Yang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib47","first-page":"217","article-title":"Treatment of Autosomal Dominant Hearing Loss by in Vivo Delivery of Genome Editing Agents","volume":"553","author":"Gao","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib48","first-page":"53","article-title":"Precision Cancer Mouse Models through Genome Editing with CRISPR-Cas9","volume":"7","author":"Mou","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.omtn.2026.103003_bib49","first-page":"583","article-title":"Genome-Scale Transcriptional Activation by an Engineered CRISPR-Cas9 Complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib50","first-page":"80","article-title":"Genetic Screens in Human Cells Using the CRISPR-Cas9 System","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib51","first-page":"2602","article-title":"Repurposing CRISPR\/Cas9 for in Situ Functional Assays","volume":"27","author":"Malina","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2026.103003_bib52","first-page":"511","article-title":"Prioritization of Cancer Therapeutic Targets Using CRISPR-Cas9 Screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib53","first-page":"5416","article-title":"Optimized Libraries for CRISPR-Cas9 Genetic Screens with Multiple Modalities","volume":"9","author":"Sanson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103003_bib54","first-page":"573","article-title":"Combinatorial CRISPR-Cas9 Screens for de Novo Mapping of Genetic Interactions","volume":"14","author":"Shen","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103003_bib55","first-page":"172","article-title":"Mechanisms of PARP Inhibitor Sensitivity and Resistance","volume":"71","author":"D\u2019Andrea","year":"2018","journal-title":"DNA Repair"},{"key":"10.1016\/j.omtn.2026.103003_bib56","first-page":"217","article-title":"Accurate Classification of BRCA1 Variants with Saturation Genome Editing","volume":"562","author":"Findlay","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib57","first-page":"117","article-title":"The Shieldin Complex Mediates 53BP1-Dependent DNA Repair","volume":"560","author":"Noordermeer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib58","first-page":"285","article-title":"CRISPR Screens Identify Genomic Ribonucleotides as a Source of PARP-Trapping Lesions","volume":"559","author":"Zimmermann","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib59","first-page":"149","article-title":"Search-and-Replace Genome Editing without Double-Strand Breaks or Donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103003_bib60","first-page":"1786","article-title":"Prime Editing with Genuine Cas9 Nickases Minimizes Unwanted Indels","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103003_bib61","first-page":"1381","article-title":"Emerging Trends in Prime Editing for Precision Genome Editing","volume":"57","author":"Lee","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib62","article-title":"Precise Correction of Duchenne Muscular Dystrophy Exon Deletion Mutations by Base and Prime Editing","volume":"7","author":"Chemello","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.103003_bib63","first-page":"181","article-title":"Application of Prime Editing to the Correction of Mutations and Phenotypes in Adult Mice with Liver and Eye Diseases","volume":"6","author":"Jang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.103003_bib64","first-page":"2121","article-title":"Improved Prime Editors Enable Pathogenic Allele Correction and Cancer Modelling in Adult Mice","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103003_bib65","article-title":"In Vivo Prime Editing of a Metabolic Liver Disease in Mice","volume":"14","author":"B\u00f6ck","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib66","first-page":"1000","article-title":"Prime Editing: Advances and Therapeutic Applications","volume":"41","author":"Zhao","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtn.2026.103003_bib67","first-page":"577","article-title":"Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening","volume":"170","author":"McDonald","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib68","first-page":"564","article-title":"Defining a Cancer Dependency Map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib69","first-page":"957","article-title":"Cas9 as a Versatile Tool for Engineering Biology","volume":"10","author":"Mali","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103003_bib70","first-page":"1279","article-title":"Targeted Genome Editing in Human Cells with Zinc Finger Nucleases Constructed via Modular Assembly","volume":"19","author":"Kim","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2026.103003_bib71","first-page":"702","article-title":"Mutation Detection Using Surveyor Nuclease","volume":"36","author":"Qiu","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.omtn.2026.103003_bib72","article-title":"Easy Quantitative Assessment of Genome Editing by Sequence Trace Decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103003_bib74","first-page":"120","article-title":"Deconvolution of Complex DNA Repair (DECODR): Establishing a Novel Deconvolution Algorithm for Comprehensive Analysis of CRISPR-Edited Sanger Sequencing Data","volume":"4","author":"Bloh","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtn.2026.103003_bib75","first-page":"205","article-title":"CRISPR-Cas Guide RNA Indel Analysis Using CRISPResso2 with Nanopore Sequencing Data","volume":"17","author":"McFarlane","year":"2024","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.omtn.2026.103003_bib76","first-page":"267","article-title":"Genome-Wide Recessive Genetic Screening in Mammalian Cells with a Lentiviral CRISPR-Guide RNA Library","volume":"32","author":"Koike-Yusa","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103003_bib77","first-page":"675","article-title":"A Genome-Wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks","volume":"162","author":"Parnas","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib78","first-page":"1883","article-title":"Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq","volume":"167","author":"Jaitin","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib79","first-page":"1853","article-title":"Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens","volume":"167","author":"Dixit","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib80","first-page":"1867","article-title":"A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response","volume":"167","author":"Adamson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib81","first-page":"297","article-title":"Pooled CRISPR Screening with Single-Cell Transcriptome Readout","volume":"14","author":"Datlinger","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103003_bib82","first-page":"361","article-title":"Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks","volume":"176","author":"Rubin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib83","first-page":"865","article-title":"Simultaneous Epitope and Transcriptome Measurement in Single Cells","volume":"14","author":"Stoeckius","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103003_bib84","first-page":"285","article-title":"Multiplexed Engineering and Analysis of Combinatorial Enhancer Activity in Single Cells","volume":"66","author":"Xie","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib85","first-page":"629","article-title":"Targeted Perturb-Seq Enables Genome-Scale Genetic Screens in Single Cells","volume":"17","author":"Schraivogel","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103003_bib86","first-page":"954","article-title":"Combinatorial Single-Cell CRISPR Screens by Direct Guide RNA Capture and Targeted Sequencing","volume":"38","author":"Replogle","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103003_bib87","first-page":"787","article-title":"Optical Pooled Screens in Human Cells","volume":"179","author":"Feldman","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib88","first-page":"563","article-title":"Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy of Chronic Lymphocytic Leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib89","first-page":"728","article-title":"Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies","volume":"181","author":"Roth","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib90","first-page":"4216","article-title":"Modular Pooled Discovery of Synthetic Knockin Sequences to Program Durable Cell Therapies","volume":"186","author":"Blaeschke","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103003_bib91","first-page":"322","article-title":"Characterizing the Molecular Regulation of Inhibitory Immune Checkpoints with Multimodal Single-Cell Screens","volume":"53","author":"Papalexi","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.103003_bib92","first-page":"15","article-title":"SCANPY: Large-Scale Single-Cell Gene Expression Data Analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.103003_bib93","first-page":"19","article-title":"scMAGeCK Links Genotypes with Multiple Phenotypes in Single-Cell CRISPR Screens","volume":"21","author":"Yang","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.103003_bib94","first-page":"344","article-title":"SCEPTRE Improves Calibration and Sensitivity in Single-Cell CRISPR Screen Analysis","volume":"22","author":"Barry","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.103003_bib95","first-page":"2233","article-title":"Model-Based Understanding of Single-Cell CRISPR Screening","volume":"10","author":"Duan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103003_bib96","first-page":"164","article-title":"BAGEL: A Computational Framework for Identifying Essential Genes from Pooled Library Screens","volume":"17","author":"Hart","year":"2016","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omtn.2026.103003_bib97","first-page":"159","article-title":"CRISPhieRmix: A Hierarchical Mixture Model for CRISPR Pooled Screens","volume":"19","author":"Daley","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.103003_bib98","first-page":"107","article-title":"CRISPR Screening in Hematology Research: From Bulk to Single-Cell Level","volume":"16","author":"Meyers","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.omtn.2026.103003_bib99","first-page":"62","article-title":"A Benchmark of Algorithms for the Analysis of Pooled CRISPR Screens","volume":"21","author":"Bodapati","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.103003_bib100","first-page":"1218","article-title":"Dissecting Key Regulators of Transcriptome Kinetics through Scalable Single-Cell RNA Profiling of Pooled CRISPR Screens","volume":"42","author":"Xu","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103003_bib101","first-page":"732","article-title":"Safety and Feasibility of CRISPR-Edited T Cells in Patients with Refractory Non-Small-Cell Lung Cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib102","first-page":"1240","article-title":"CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib103","article-title":"CRISPR-Engineered T Cells in Patients with Refractory Cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103003_bib104","series-title":"CRISPR and the Ethics of Human Genome Editing","year":"2019"},{"key":"10.1016\/j.omtn.2026.103003_bib107","first-page":"885","article-title":"International Call for a 10-Year Moratorium on Heritable Human Genome Editing: A Multi-Stakeholder Initiative to Ensure Safe and Responsible Use of Genetic Technologies May 2025","volume":"27","author":"Barrett","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtn.2026.103003_bib108","first-page":"1259","article-title":"Perinatal Outcome and Congenital Malformations in In-Vitro Fertilization Babies from the Bourn-Hallam Group","volume":"6","author":"Rizk","year":"1991","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.omtn.2026.103003_bib109","first-page":"366","article-title":"BIRTH AFTER THE REIMPLANTATION OF A HUMAN EMBRYO","volume":"2","author":"Steptoe","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2026.103003_bib110","first-page":"252","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib111","article-title":"Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.omtn.2026.103003_bib112","first-page":"11","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib113","first-page":"493","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omtn.2026.103003_bib114","article-title":"CRISPR-Cas9-Mediated Therapeutics: Current Clinical Trials and Therapy Approval Landscape to Treat Human Diseases","volume":"37","author":"Chakraborty","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103003_bib115","first-page":"2235","article-title":"Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103003_bib116","first-page":"1097","article-title":"Field Assessment of Genome-Edited, Low Asparagine Wheat: Europe\u2019s First CRISPR Wheat Field Trial","volume":"21","author":"Raffan","year":"2023","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.omtn.2026.103003_bib117","article-title":"Spider Eye Development Editing and Silk Fiber Engineering Using CRISPR-Cas","volume":"64","author":"Santiago-Rivera","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omtn.2026.103003_bib118","author":"Jeffrey"},{"key":"10.1016\/j.omtn.2026.103003_bib119","unstructured":"Colossal Foundation Restoring the Ancestral Red Wolf Through Genetic Rescue, https:\/\/colossalfoundation.org\/project\/restoring-the-ancestral-red-wolf-through-genetic-rescue\/."},{"key":"10.1016\/j.omtn.2026.103003_bib120","first-page":"e264","article-title":"Off-Target Effects in CRISPR\/Cas9-Mediated Genome Engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103003_bib121","first-page":"1020","article-title":"Gene Disruption by Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA","volume":"24","author":"Ramakrishna","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2026.103003_bib122","first-page":"1012","article-title":"Highly Efficient RNA-Guided Genome Editing in Human Cells via Delivery of Purified Cas9 Ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2026.103003_bib123","first-page":"5405","article-title":"Comparison of Non-Canonical PAMs for CRISPR\/Cas9-Mediated DNA Cleavage in Human Cells","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103003_bib124","article-title":"CRISPR\/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off-Target Evaluation, and Strategies to Mitigate Off-Target Effects","volume":"7","author":"Manghwar","year":"2020","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.omtn.2026.103003_bib125","article-title":"CRISPR System: Discovery, Development and off-Target Detection","volume":"70","author":"Chen","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.omtn.2026.103003_bib126","first-page":"1349","article-title":"Genome Modelling and Design across All Domains of Life with Evo 2","volume":"652","author":"Brixi","year":"2026","journal-title":"Nature"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:09:26Z","timestamp":1788880166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126001745"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103003","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPRing through time: How cutting-edge technology is revolutionizing life sciences and medicine","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103003"}}